350 related articles for article (PubMed ID: 10181369)
1. The dangers of self-dosing.
Schultz S
US News World Rep; 1998 Jul; 125(2):58. PubMed ID: 10181369
[No Abstract] [Full Text] [Related]
2. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
Moxley JH; Yingling GL; Edwards CC
Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
[No Abstract] [Full Text] [Related]
3. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
Hayes TA
Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
[No Abstract] [Full Text] [Related]
4. FDA considers OTC drug labeling reform.
Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
[No Abstract] [Full Text] [Related]
5. Drug labeling and promotion: evolution and application of regulatory policy.
Hayes TA
Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353
[No Abstract] [Full Text] [Related]
6. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
Green W
Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
[No Abstract] [Full Text] [Related]
7. Safe & sound. Interview by Helena Gail Rubinstein.
Woodcock J
AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
[No Abstract] [Full Text] [Related]
8. New OTC drug facts label.
FDA Consum; 2002; 36(4):35. PubMed ID: 12184303
[No Abstract] [Full Text] [Related]
9. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
[No Abstract] [Full Text] [Related]
10. Over-the-counter sales of statins and other drugs for asymptomatic conditions.
Tinetti ME
N Engl J Med; 2008 Jun; 358(25):2728-32. PubMed ID: 18565867
[No Abstract] [Full Text] [Related]
11. Three categories of nonprescription drug products to carry new warnings.
Clin Pharm; 1993 Nov; 12(11):800. PubMed ID: 8275645
[No Abstract] [Full Text] [Related]
12. The dilemma over foreign-language labeling of over-the-counter drugs.
Maciejewski CS
J Leg Med; 1994 Mar; 15(1):129-54. PubMed ID: 8201275
[No Abstract] [Full Text] [Related]
13. Nonprescription drugs: an overview.
Hodes B
Int J Health Serv; 1974; 4(1):125-30. PubMed ID: 4829892
[No Abstract] [Full Text] [Related]
14. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
[No Abstract] [Full Text] [Related]
15. An update on the therapeutic orphan.
Wilson JT
Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
[No Abstract] [Full Text] [Related]
16. [Surfing the Internet with side effects: problems surrounding smart drugs].
Hesselink JM
Dtsch Med Wochenschr; 1999 Jun; 124(22):707-10. PubMed ID: 10394352
[No Abstract] [Full Text] [Related]
17. OTC's: end the dual standard.
Feldmann EG
J Pharm Sci; 1973 Apr; 62(4):I. PubMed ID: 4699002
[No Abstract] [Full Text] [Related]
18. Changing over-the-counter drugs while retaining the brand name.
Merikangas JR
Ann Intern Med; 1993 Jun; 118(12):988. PubMed ID: 8489122
[No Abstract] [Full Text] [Related]
19. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
[TBL] [Abstract][Full Text] [Related]
20. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Apr; 281(13):1164. PubMed ID: 10199413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
